Purchase Order 75N95D21P00021

The National Institute on Aging awarded a $24,995 firm fixed-price purchase order to Oxford Nanopore Technologies Inc. for software licenses and device warranty services related to the PromethION-24 sequencer. The contract was awarded on August 15, 2025, with an ultimate completion date of August 14, 2026, and will be performed in New York, NY. This award carries no set-aside designation and represents Oxford Nanopore's continued provision of next-generation sequencing technologies to federal...

The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $185,835 firm fixed-price purchase order to Oxford Nanopore Technologies Inc. for the delivery of PromethION flow cell packs for long-read DNA and RNA/cDNA sequencing. Per the solicitation, the Government sought these products and associated packaging, marking, shipping, and delivery services to 251 Bayview Blvd in Baltimore, Maryland within 90 days of order receipt. As specified,...

The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $20,000 purchase order to Oxford Nanopore Technologies Inc. for SOFTWARE LICENSE AND DEVICE WARRANTY SERVICES - PROMETHION-24 SEQUENCER. Oxford Nanopore Technologies Inc. will provide software licenses and device warranty services for its PromethION-24 sequencer under the firm fixed price contract. Performance will take place in Baltimore, Maryland over a one year period from August...

<p>The National Human Genome Research Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for $50,065.00 on September 7, 2017, for an Oxford Nanopore Starter Pack—a device providing ultra-long read DNA and RNA sequencing using nanopores. Work is performed in Bethesda, Maryland. The order carries a firm fixed price and was scheduled for completion by October 20, 2017.</p>

Oxford Nanopore Technologies Inc. was awarded a firm fixed-price purchase order valued at $354,850 by the National Institute on Drug Abuse on September 16, 2020, for the provision of full-length RNA sequencing supplies to support the National Institute on Aging's research activities. The contract, which was completed on June 15, 2022, was not associated with any set-aside designation. The supplies were to be delivered to Cambridge, Massachusetts, and the award was issued in part to...

This firm fixed-price purchase order is valued at $30,000 and was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Aging to Oxford Nanopore Technologies Inc. The order is for a software license and device warranty to support the Nanopore Promethion Long Read Sequencer serial number P48_051 located at the NIH in Bethesda, Maryland. The sequencing platform will be used over the period of performance from July 2023 to July 2024 by the NIH's...

This federal contract award is for the provision of Oxford Nanopore long read sequencing kits to the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH). The $550,333 firm-fixed-price purchase order was awarded to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company specializing in nanopore-based sequencing technologies. The contract does not have a set-aside designation. The contract was awarded to administratively...

The National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $197,755 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the delivery of a PROMETHION 24 THIRD GENERATION SEQUENCER to support the NIA's Computational Biology &amp; Genomics Core, which provides next-generation sequencing services for aging-related research at the NIA Intramural...

This is a $23,050.00 firm fixed price purchase order awarded to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services. The contract is for the delivery of a PromethION 2 Solo CAPEX Sequencing Unit, a next-generation genomic sequencing platform developed by Oxford Nanopore. This award is not associated with a set-aside program and is the latest in a...

<p>The National Heart Lung and Blood Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for a nanopore direct RNA sequencing system valued at $50,105.35 on August 19, 2020. The system is to be delivered to Bethesda, Maryland. Work is firm fixed price with an ultimate completion date of August 21, 2020. The purchase order originated from a special notice posted August 7, 2020, and carried no small business set-aside.</p>